Differential effects of high salt intake on neuropeptide Y and adrenergic markers in hearts of Dahl rats

Peptides

Volumn 19, Issue 8, 1998, Pages 1377-1383

  Nyquist Battie, Cynthia ^a   Cochran, Pamala ^a   Chronwall, Bibie M ^a,b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b UNIVERSITY OF NORTH FLORIDA   (United States)

Author keywords

Cardiac Hypertrophy; Dahl Salt Sensitive Rats; Heart; Nerve Growth Factor; Neuropeptide Y; Norepinephrine; Sympathetic Nervous System

Indexed keywords

DOPAMINE BETA MONOOXYGENASE; NERVE GROWTH FACTOR; NEUROPEPTIDE Y; NEUROTROPHIN RECEPTOR; NORADRENALIN; SODIUM CHLORIDE; TYROSINE 3 MONOOXYGENASE;

ADRENERGIC SYSTEM; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; HEART LEFT VENTRICLE HYPERTROPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SALT INTAKE;

ADRENERGIC AGENTS; ANIMALS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MYOCARDIUM; NERVE GROWTH FACTORS; NEUROPEPTIDE Y; NOREPINEPHRINE; RATS; RATS, INBRED DAHL; SODIUM CHLORIDE, DIETARY; SYMPATHETIC NERVOUS SYSTEM;

ANIMALIA;

EID: 0031758711     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(98)00101-6     Document Type: Article

References (32)

1. Bohm M., LaRosee K., Schwinger R.H.G., Erdmann E. Evidence for reduction of norepinephrine uptake sites in the failing human heart. J. Am. Coll. Cardiol. 25:1995;146-153.
2. Brooks V.L. Interactions between angiotensin II and the sympathetic nervous system in the long-term control of arterial pressure. Clin. Exper. Pharmacol. Physiol. 24:1997;83-90.
3. Castagne V.R., Corder R., Gaillard R., Mormede P. Stress-induced changes of circulating neuropeptide Y in the rat Comparison with catecholamines . Regul. Pept. 19:1987;55-63.
4. Chen J., Jennings G.L., Goldstein D.S. Sympathetic nervous function in human heart as assessed by cardiac spillover of dihydroxyphenylglycol and norepinephrine. Circulation. 85:1992;1775-1785.
5. Clegg D.O., Large T.H., Bodary S.C., Reichardt L.F. Regulation of nerve growth factor mRNA levels in developing rat heart ventricle is not altered by sympathectomy. Devel. Biol. 134:1989;30-37.
6. Cubells J.F., Baker H., Volpe B.T., Smith G.P., Das S.S., Joh T.H. Innervation-independent changes in the mRNAs encoding tyrosine hydroxylase and the norepinephrine transporter in rat adrenal medulla after high-dose reserpine. Neuroscience Letts. 193:1995;189-192.
7. Eisenhofer G., Esler M.D., Meredith I.T., Dart A., Cannon R.O., Quyyumi A.A., Lambert G., Chen J., Jennings G.L., Goldstein D.S. Sympathetic nervous function in human heart as assessed by cardiac spillover of dihydroxyphenylglycol and norepinephrine. Circulation. 85:1992;1775-1785.
8. Ganguly P.K., Lee S.-L., Beamish R.E., Dhalla N.S. Altered sympathetic system and adrenoceptors during the development of cardiac hypertrophy. Am. Heart J. 18:1989;520-525.
9. Haas M., Cheng B., Richardt G., Lang R.E., Schomig A. Characterization and presynaptic modulation of stimulation-evoked exocytotic co-release of norepinephrine and neuropeptide Y in guinea pig heart. Naunyn-Schmiedeberg's Arch. Pharmacol. 339:1989;71-78.
10. Hamill R.W., Schroeder B. Hormonal regulation of adult sympathetic neurons The effects of castration on neuropeptide Y, norepinephrine, and tyrosine hydroxylase activity . J. Neurobiol. 21:1990;731-742.
11. Hanze J., Kummer W., Haass M., Lang R.E. Neuropeptide Y mRNA regulation in rat sympathetic ganglia; effect of reserpine. Neurosci. Lett. 124:1991;119-121.
12. Howe P.R.C., Rogers P.F., Morris M.J., Chalmers J.P., Smith R.M. Plasma catecholamines and neuropeptide Y as indices of sympathetic nerve activity in normotensive and stroke-prone spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 8:1986;1113-1121.
13. Krukoff T.L., Zheng Y. Gene expression of tyrosine hydroxylase and neuropeptide Y in prevertebral ganglia of renal hypertensive rats. Am. J. Physiol. 261:1991;1455-1460.
14. Lerchen R.A., Yum D.-Y., Krajcik R., Minth-Worby C.A. Transcriptional vs. postranscriptional control of neuropeptide Y gene expression. Endocrinology. 136:1995;833-841.
15. Lindpaintner K., Lund D.D., Schmid P.G. Role of myocardial hypertrophy in trophic stimulation of indices of sympathetic cardiac innervation. J. Cardiovasc. Pharmacol. 10:(Suppl. 12):1987;S211-S220.
16. Love S., Nyquist-Battie C., Chronwall B.M. Diminished NPY immunoreactivity in a guinea pig model of left ventricular hypertrophy. Cardiovasc. Res. 27:1993;494-499.
17. Mark A.L. Sympathetic neural contribution to salt-induced hypertension in Dahl rats. Hypertension. 17:1991;186-190.
18. Miller F.D., Speelman A., Mathew T.C., Fabian J., Chang E., Pozmiak C., Toma J.G. Nerve growth factor derived from terminals selectively increases the ratio of p75 to trkA NGF receptors on mature sympathetic neurons. Dev. Biol. 161:1994;206-217.
19. Minth-Worby C.A. Transcriptional regulation of human neuropeptide Y gene by nerve growth factor. J. Biol. Chem. 269:1994;15460-15468.
20. Nyquist-Battie C., Cochran P.K., Evans V.R., Hitchcock J.M., Unal C. Regulation of sympathetic presynaptic components in rat left ventricle during ligation of the abdominal aorta. Am. J. Physiol. 271:1996;H1547-H1554.
21. Nyquist-Battie C., Cochran P.K., Sands S.A., Chronwall B.M. Development of neuropeptide Y and tyrosine hydroxylase immunoreactive innervation in postnatal rat heart. Peptides. 15:1994;1461-1469.
22. Osborn J.W. Hormones as long-term error signals for the sympathetic nervous system Importance of a new perspective . Clin. Exp. Pharmacol. Physiol. 24:1997;109-115.
23. Peuler J.D., Patel K.P., Morgan D.A., Whiteis C.A., Lund D.D., Pardini B.J., Schmid P.G. Altered peripheral noradrenergic activity in intact and sinoaortic denervated Dahl rats. Can. J. Physiol. Pharmacol. 67:1989;442-449.
24. Pfeffer M.A., Pfeffer J., Mirsky I., Iwai J. Cardiac hypertrophy and performance of Dahl hypertensive rats on graded salt diets. Hypertension. 6:1984;475-481.
25. Potter E.K., Ulman L.G. Neuropeptides in sympathetic nerves affect vagal regulation of the heart. News Physiol. Soc. 9:1994;174-177.
26. Rapp J.P. Dahl salt-susceptible and salt-resistant rats. Hypertension. 4:1982;753-763.
27. Schmid, P. G.; Lund, D. D.; Roskoski Jr., R. Efferent autonomic dysfunction in heart failure. In: Abboud, F. M.; ed. Disturbances in Neurogenic Control of the Circulation. American Physiological Society. 1981:33-49.
28. Siri F.M. Sympathetic changes during development of cardiac hypertrophy in aortic-constricted rats. Am. J. Physiol. 255:1988;H452-H457.
29. Tyrrell S., Siegel R.E., Landis S.C. Tyrosine hydroxylase and neuropeptide Y are increased in ciliary ganglia of sympathectomized rats. Neuroscience. 47:1992;985-998.
30. Warner M.R., Levy M.N. Role of neuropeptide Y in neural control of the heart. J. Cardiovasc. Electrophysiol. 1:1990;80-91.
31. Yuan B., Leenen F.H.H. Dietary sodium intake and left ventricular hypertrophy in normotensive rats. Am. J. Physiol. 261:1991;H1397-H1401.
32. Zukowska-Grojec Z., Konarska M., McCarty R. Differential plasma catecholamine and neuropeptide Y responses to acute stress in rats. Life Sci. 42:1988;1615-1624.